speb/financial-data huggingface dataset:
FAIRCHEMOR.NS cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: 6728000.00
FAIRCHEMOR.NS cash_flow (annual, 2024-03-31) — Change In Payable: 24568000.00
FAIRCHEMOR.NS cash_flow (annual, 2024-03-31) — Change In Receivables: 58393000.00
FAIRCHEMOR.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: 195327000.00
FAIRCHEMOR.NS cash_flow (annual, 2024-03-31) — Changes In Cash: 6000.00
FAIRCHEMOR.NS balance_sheet (annual, 2024-03-31) — Common Stock: 130209000.00
FAIRCHEMOR.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 2899328000.00
FAIRCHEMOR.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 79011000.00
FAIRCHEMOR.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 5053948000.00
FAIRCHEMOR.NS balance_sheet (annual, 2024-03-31) — Current Assets: 1328525000.00
FAIRCHEMOR.NS balance_sheet (annual, 2024-03-31) — Current Debt: 73177000.00
FAIRCHEMOR.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 73177000.00
FAIRCHEMOR.NS balance_sheet (annual, 2024-03-31) — Current Deferred Taxes Liabilities: 616000.00
FAIRCHEMOR.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 260652000.00
FAIRCHEMOR.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 11301000.00
FAIRCHEMOR.NS cash_flow (annual, 2024-03-31) — Depreciation: 90918000.00
FAIRCHEMOR.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 92784000.00
FAIRCHEMOR.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 92783000.00
FAIRCHEMOR.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 90917000.00
FAIRCHEMOR.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 13020902.00
FAIRCHEMOR.NS income_statement (annual, 2024-03-31) — Diluted EPS: 31.10
FAIRCHEMOR.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 405003000.00
FAIRCHEMOR.NS balance_sheet (annual, 2024-03-31) — Dividends Payable: 818000.00
FAIRCHEMOR.NS income_statement (annual, 2024-03-31) — EBIT: 588353000.00
FAIRCHEMOR.NS income_statement (annual, 2024-03-31) — EBITDA: 681137000.00
FAIRCHEMOR.NS cash_flow (annual, 2024-03-31) — End Cash Position: 84000.00
FAIRCHEMOR.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: -568549000.00
FAIRCHEMOR.NS balance_sheet (annual, 2024-03-31) — Finished Goods: 43875000.00
FAIRCHEMOR.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: 563525000.00
FAIRCHEMOR.NS cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: -317000.00
FAIRCHEMOR.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 44011000.00
FAIRCHEMOR.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 3470000.00
FAIRCHEMOR.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 572330000.00
FAIRCHEMOR.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 2489457000.00
FAIRCHEMOR.NS income_statement (annual, 2024-03-31) — Gross Profit: 1129125000.00
FAIRCHEMOR.NS income_statement (annual, 2024-03-31) — Interest Expense: 42393000.00
FAIRCHEMOR.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 42393000.00
FAIRCHEMOR.NS income_statement (annual, 2024-03-31) — Interest Income: 423000.00
FAIRCHEMOR.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 423000.00
FAIRCHEMOR.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -42393000.00
FAIRCHEMOR.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 346000.00
FAIRCHEMOR.NS balance_sheet (annual, 2024-03-31) — Inventory: 697016000.00
FAIRCHEMOR.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 2972505000.00
FAIRCHEMOR.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: -176250000.00
FAIRCHEMOR.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 2097000.00
FAIRCHEMOR.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 52250000.00
FAIRCHEMOR.NS cash_flow (annual, 2024-03-31) — Long Term Debt Payments: 0.00
FAIRCHEMOR.NS balance_sheet (annual, 2024-03-31) — Long Term Provisions: 21871000.00
FAIRCHEMOR.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 2033991000.00
FAIRCHEMOR.NS balance_sheet (annual, 2024-03-31) — Net Debt: 73093000.00
FAIRCHEMOR.NS cash_flow (annual, 2024-03-31) — Net Foreign Currency Exchange Gain Loss: -782000.00
FAIRCHEMOR.NS income_statement (annual, 2024-03-31) — Net Income: 405003000.00
FAIRCHEMOR.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 405003000.00
FAIRCHEMOR.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 405003000.00
FAIRCHEMOR.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 405003000.00
FAIRCHEMOR.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 405003000.00
FAIRCHEMOR.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 545960000.00
FAIRCHEMOR.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 405003000.00
FAIRCHEMOR.NS income_statement (annual, 2024-03-31) — Net Interest Income: -41970000.00
FAIRCHEMOR.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: -428499000.00
FAIRCHEMOR.NS cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: 0.00
FAIRCHEMOR.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: -41970000.00
FAIRCHEMOR.NS balance_sheet (annual, 2024-03-31) — Net PPE: 1987789000.00
FAIRCHEMOR.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -176596000.00
FAIRCHEMOR.NS cash_flow (annual, 2024-03-31) — Net Short Term Debt Issuance: -428499000.00
FAIRCHEMOR.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 2895858000.00
FAIRCHEMOR.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 161243000.00
FAIRCHEMOR.NS balance_sheet (annual, 2024-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 21871000.00
FAIRCHEMOR.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 21532000.00
FAIRCHEMOR.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 680820000.00
FAIRCHEMOR.NS income_statement (annual, 2024-03-31) — Normalized Income: 404767843.67
FAIRCHEMOR.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 744805000.00
FAIRCHEMOR.NS income_statement (annual, 2024-03-31) — Operating Income: 577015000.00
FAIRCHEMOR.NS income_statement (annual, 2024-03-31) — Operating Revenue: 6183073000.00
FAIRCHEMOR.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 13020902.00
FAIRCHEMOR.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 62096000.00
FAIRCHEMOR.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 9549000.00
FAIRCHEMOR.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 2769119000.00
FAIRCHEMOR.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 3470000.00
FAIRCHEMOR.NS balance_sheet (annual, 2024-03-31) — Other Inventories: 717000.00
FAIRCHEMOR.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: 41970000.00
FAIRCHEMOR.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: 21278000.00
FAIRCHEMOR.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 396000.00
FAIRCHEMOR.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 110053000.00
FAIRCHEMOR.NS balance_sheet (annual, 2024-03-31) — Other Payable: 32683000.00
FAIRCHEMOR.NS balance_sheet (annual, 2024-03-31) — Other Properties: 51068000.00
FAIRCHEMOR.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 3531000.00
FAIRCHEMOR.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 1057000.00
FAIRCHEMOR.NS income_statement (annual, 2024-03-31) — Other Special Charges: -317000.00
FAIRCHEMOR.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
FAIRCHEMOR.NS balance_sheet (annual, 2024-03-31) — Payables: 163721000.00
FAIRCHEMOR.NS balance_sheet (annual, 2024-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 11301000.00
FAIRCHEMOR.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 58946000.00
FAIRCHEMOR.NS income_statement (annual, 2024-03-31) — Pretax Income: 545960000.00
FAIRCHEMOR.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
FAIRCHEMOR.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -181280000.00
FAIRCHEMOR.NS balance_sheet (annual, 2024-03-31) — Raw Materials: 348145000.00
FAIRCHEMOR.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 5053948000.00
FAIRCHEMOR.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 92784000.00
FAIRCHEMOR.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 4103000.00
FAIRCHEMOR.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 4103000.00
FAIRCHEMOR.NS cash_flow (annual, 2024-03-31) — Repayment Of Debt: 0.00
FAIRCHEMOR.NS income_statement (annual, 2024-03-31) — Research And Development: 4337000.00
FAIRCHEMOR.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 818000.00
FAIRCHEMOR.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: 1873314000.00
FAIRCHEMOR.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 4684000.00
FAIRCHEMOR.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 73675000.00
FAIRCHEMOR.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 117686000.00
FAIRCHEMOR.NS balance_sheet (annual, 2024-03-31) — Share Issued: 13020902.00
FAIRCHEMOR.NS income_statement (annual, 2024-03-31) — Special Income Charges: 317000.00
FAIRCHEMOR.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 2899328000.00
FAIRCHEMOR.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 2895858000.00
FAIRCHEMOR.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 81843.67
FAIRCHEMOR.NS income_statement (annual, 2024-03-31) — Tax Provision: 140957000.00
FAIRCHEMOR.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.26
FAIRCHEMOR.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -130137000.00
FAIRCHEMOR.NS balance_sheet (annual, 2024-03-31) — Total Assets: 3343094000.00
FAIRCHEMOR.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 2899328000.00
FAIRCHEMOR.NS balance_sheet (annual, 2024-03-31) — Total Debt: 73177000.00
FAIRCHEMOR.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 2899328000.00
FAIRCHEMOR.NS income_statement (annual, 2024-03-31) — Total Expenses: 5606058000.00
FAIRCHEMOR.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 443766000.00
FAIRCHEMOR.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 2014569000.00
FAIRCHEMOR.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 183114000.00
FAIRCHEMOR.NS balance_sheet (annual, 2024-03-31) — Total Tax Payable: 616000.00
FAIRCHEMOR.NS income_statement (annual, 2024-03-31) — Total Unusual Items: 317000.00
FAIRCHEMOR.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: 317000.00
FAIRCHEMOR.NS balance_sheet (annual, 2024-03-31) — Work In Process: 304279000.00
FAIRCHEMOR.NS balance_sheet (annual, 2024-03-31) — Working Capital: 1067873000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 136259000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 806125000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 2354000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 130209000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 101000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 1336000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 130209000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 2979039000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 148041000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 1656969000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2024-09-30) — Current Debt: 443183000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 443183000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 649691000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2024-09-30) — Current Provisions: 13272000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 2517000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 2054340000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2024-09-30) — Inventory: 773782000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 3422222000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 2354000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2024-09-30) — Long Term Provisions: 27635000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2024-09-30) — Net Debt: 443082000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 2054340000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 2976522000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Liabilities: 169956000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 13020902.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 75041000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 46840000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 2848830000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 40651000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2024-09-30) — Other Properties: 1906299000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2024-09-30) — Other Receivables: 685000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 1235000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2024-09-30) — Payables: 136259000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 13020902.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 2979039000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 2976522000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 3826321000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 2979039000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 443183000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 2979039000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 847282000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 2169352000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 197591000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2024-09-30) — Total Tax Payable: 0.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: 1007278000.00
FAIRCHEMOR.NS income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
FAIRCHEMOR.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items: 0.00
FAIRCHEMOR.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
FAIRCHEMOR.NS income_statement (annual, 2025-03-31) — +Operating Expense: 603607000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 246963000.00
FAIRCHEMOR.NS income_statement (annual, 2025-03-31) — +Total Revenue: 5362926000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 1207807000.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 83374000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 83374000.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 861338000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 861338000.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -603426000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -603426000.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 0.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 0.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -4200000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -4200000.00
FAIRCHEMOR.NS income_statement (annual, 2025-03-31) — Amortization: 1902000.00
FAIRCHEMOR.NS cash_flow (annual, 2025-03-31) — Amortization Cash Flow: 1902000.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Assets Held For Sale Current: 0.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Assets Held For Sale Current: 0.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 2354000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 2354000.00
FAIRCHEMOR.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 13020902.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 12906522.00
FAIRCHEMOR.NS income_statement (annual, 2025-03-31) — Basic EPS: 16.88
FAIRCHEMOR.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 0.46
FAIRCHEMOR.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 84000.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 273740000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 273740000.00
FAIRCHEMOR.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -261090000.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 130209000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 130209000.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 82000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 82000.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 11536000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 11536000.00
FAIRCHEMOR.NS cash_flow (annual, 2025-03-31) — Cash Dividends Paid: -97657000.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 82000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 82000.00
FAIRCHEMOR.NS cash_flow (annual, 2025-03-31) — Change In Inventory: -186044000.00
FAIRCHEMOR.NS cash_flow (annual, 2025-03-31) — Change In Other Current Assets: 12767000.00
FAIRCHEMOR.NS cash_flow (annual, 2025-03-31) — Change In Other Current Liabilities: -866000.00
FAIRCHEMOR.NS cash_flow (annual, 2025-03-31) — Change In Payable: -47229000.00
FAIRCHEMOR.NS cash_flow (annual, 2025-03-31) — Change In Receivables: -292711000.00
FAIRCHEMOR.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: -509948000.00
FAIRCHEMOR.NS cash_flow (annual, 2025-03-31) — Changes In Cash: -2000.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Common Stock: 130209000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 130209000.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 3020306000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 3020306000.00
FAIRCHEMOR.NS cash_flow (annual, 2025-03-31) — Common Stock Payments: 0.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 127109000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 127109000.00
FAIRCHEMOR.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 4433377000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 943060000.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Current Assets: 1805836000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 1805836000.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Current Debt: 630319000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 630319000.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 630319000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 630319000.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Current Deferred Taxes Liabilities: 0.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Current Deferred Taxes Liabilities: 0.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 785583000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 785583000.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 13689000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 13689000.00
FAIRCHEMOR.NS cash_flow (annual, 2025-03-31) — Depreciation: 103440000.00
FAIRCHEMOR.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 105342000.00
FAIRCHEMOR.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 105342000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 26403000.00
FAIRCHEMOR.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 103440000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 26403000.00
FAIRCHEMOR.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 13020902.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 12906522.00
FAIRCHEMOR.NS income_statement (annual, 2025-03-31) — Diluted EPS: 16.88
FAIRCHEMOR.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.46
FAIRCHEMOR.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 219743000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 5937000.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Dividends Payable: 1325000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 1325000.00
FAIRCHEMOR.NS income_statement (annual, 2025-03-31) — EBIT: 335867000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-03-31) — EBIT: 20223000.00
FAIRCHEMOR.NS income_statement (annual, 2025-03-31) — EBITDA: 441209000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-03-31) — EBITDA: 46626000.00
FAIRCHEMOR.NS cash_flow (annual, 2025-03-31) — End Cash Position: 82000.00
FAIRCHEMOR.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: 422822000.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Finished Goods: 59498000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Finished Goods: 59498000.00
FAIRCHEMOR.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: -428878000.00
FAIRCHEMOR.NS cash_flow (annual, 2025-03-31) — Gain Loss On Investment Securities: 3462000.00
FAIRCHEMOR.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 49615000.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 1594000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 1594000.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 865538000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 865538000.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 2741760000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 2741760000.00
FAIRCHEMOR.NS income_statement (annual, 2025-03-31) — Gross Profit: 929549000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 264747000.00
FAIRCHEMOR.NS income_statement (annual, 2025-03-31) — Interest Expense: 36663000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 9100000.00
FAIRCHEMOR.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 36663000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 9100000.00
FAIRCHEMOR.NS income_statement (annual, 2025-03-31) — Interest Income: 568000.00
FAIRCHEMOR.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 568000.00
FAIRCHEMOR.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -36663000.00
FAIRCHEMOR.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 670000.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Inventory: 883060000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 883060000.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 3650625000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 3650625000.00
FAIRCHEMOR.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -255036000.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 2354000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 2354000.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 52250000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 52250000.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 25099000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 25099000.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 2238030000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 2238030000.00
FAIRCHEMOR.NS cash_flow (annual, 2025-03-31) — Net Common Stock Issuance: 0.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Net Debt: 630237000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Net Debt: 630237000.00
FAIRCHEMOR.NS cash_flow (annual, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: -100000.00
FAIRCHEMOR.NS income_statement (annual, 2025-03-31) — Net Income: 219743000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-03-31) — Net Income: 5937000.00
FAIRCHEMOR.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 219743000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 5937000.00
FAIRCHEMOR.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 219743000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 5937000.00
FAIRCHEMOR.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 219743000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 5937000.00
FAIRCHEMOR.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 219743000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 5937000.00
FAIRCHEMOR.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 299204000.00
FAIRCHEMOR.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 219743000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 5937000.00
FAIRCHEMOR.NS income_statement (annual, 2025-03-31) — Net Interest Income: -36095000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -9100000.00
FAIRCHEMOR.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: 557142000.00
FAIRCHEMOR.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -36095000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -9100000.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Net PPE: 2138334000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 2138334000.00
FAIRCHEMOR.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -255706000.00
FAIRCHEMOR.NS cash_flow (annual, 2025-03-31) — Net Short Term Debt Issuance: 557142000.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 3018712000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 3018712000.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 187300000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 187300000.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 25099000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 25099000.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 70522000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 70522000.00
FAIRCHEMOR.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 444671000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 46626000.00
FAIRCHEMOR.NS income_statement (annual, 2025-03-31) — Normalized Income: 222285580.53
FAIRCHEMOR.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 5937000.00
FAIRCHEMOR.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: -167788000.00
FAIRCHEMOR.NS income_statement (annual, 2025-03-31) — Operating Income: 325942000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-03-31) — Operating Income: 17784000.00
FAIRCHEMOR.NS income_statement (annual, 2025-03-31) — Operating Revenue: 5362926000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 1207807000.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 13020902.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 13020902.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 48312000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 48312000.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 6900000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 6900000.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 2890097000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 2890097000.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 1594000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 1594000.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Other Inventories: 906000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Other Inventories: 906000.00
FAIRCHEMOR.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: 36095000.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 13114000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 13114000.00
FAIRCHEMOR.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 1634000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 2439000.00
FAIRCHEMOR.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 101776000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 162909000.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Other Payable: 38520000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 38520000.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Other Properties: 50631000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 50631000.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 3393000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 3393000.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 11454000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 11454000.00
FAIRCHEMOR.NS income_statement (annual, 2025-03-31) — Other Special Charges: 3462000.00
FAIRCHEMOR.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Payables: 123219000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Payables: 123219000.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 13689000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 13689000.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 45184000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 45184000.00
FAIRCHEMOR.NS income_statement (annual, 2025-03-31) — Pretax Income: 299204000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 11123000.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
FAIRCHEMOR.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -261090000.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Raw Materials: 352941000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Raw Materials: 352941000.00
FAIRCHEMOR.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 4433377000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 943060000.00
FAIRCHEMOR.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 105342000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 26403000.00
FAIRCHEMOR.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 4135000.00
FAIRCHEMOR.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 4135000.00
FAIRCHEMOR.NS cash_flow (annual, 2025-03-31) — Repurchase Of Capital Stock: 0.00
FAIRCHEMOR.NS income_statement (annual, 2025-03-31) — Research And Development: 4863000.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 1325000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 1325000.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 1994292000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 1994292000.00
FAIRCHEMOR.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 5384000.00
FAIRCHEMOR.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 80727000.00
FAIRCHEMOR.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 130342000.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Share Issued: 13020902.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 13020902.00
FAIRCHEMOR.NS income_statement (annual, 2025-03-31) — Special Income Charges: -3462000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 3020306000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 3020306000.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 3018712000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 3018712000.00
FAIRCHEMOR.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: -919419.47
FAIRCHEMOR.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
FAIRCHEMOR.NS income_statement (annual, 2025-03-31) — Tax Provision: 79461000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 5186000.00
FAIRCHEMOR.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.27
FAIRCHEMOR.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.30
FAIRCHEMOR.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -101844000.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Total Assets: 4018288000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 4018288000.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 3020306000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 3020306000.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Total Debt: 630319000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 630319000.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 3020306000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 3020306000.00
FAIRCHEMOR.NS income_statement (annual, 2025-03-31) — Total Expenses: 5036984000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 1190023000.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 997982000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 997982000.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 2212452000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 2212452000.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 212399000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 212399000.00
FAIRCHEMOR.NS income_statement (annual, 2025-03-31) — Total Unusual Items: -3462000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
FAIRCHEMOR.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: -3462000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Work In Process: 469715000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Work In Process: 469715000.00
FAIRCHEMOR.NS balance_sheet (annual, 2025-03-31) — Working Capital: 1020253000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 1020253000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 217350000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 1310631000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 13040000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 0.90
FAIRCHEMOR.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 1068409000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 27354000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 27354000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 13040000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.90
FAIRCHEMOR.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 11736000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-06-30) — EBIT: 26208000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-06-30) — EBITDA: 53562000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 242222000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 10052000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 10052000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-06-30) — Net Income: 11736000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 11736000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 11736000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 11736000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 11736000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 11736000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -10052000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -10052000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 53562000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 11736000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-06-30) — Operating Income: 24872000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 1310631000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 1336000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 129843000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 16156000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 1068409000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 27354000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 4420000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.27
FAIRCHEMOR.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 1285759000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-09-30) — +Operating Expense: 212514000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-09-30) — +Total Revenue: 1115227000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 103854000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 625086000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 2398000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 13088136.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-09-30) — Basic EPS: 0.59
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 130209000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 122000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 13289000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-09-30) — Common Stock: 130209000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 2940435000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 136896000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 888584000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-09-30) — Current Assets: 1599409000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-09-30) — Current Debt: 544043000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 544043000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 723965000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-09-30) — Current Provisions: 14540000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 27750000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 27750000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 13088136.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.59
FAIRCHEMOR.NS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 7722000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-09-30) — EBIT: 17872000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-09-30) — EBITDA: 45622000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 707000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 2130792000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-09-30) — Gross Profit: 226643000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-09-30) — Interest Expense: 6096000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 6096000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-09-30) — Inventory: 883424000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 3484478000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 2398000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 26350000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-09-30) — Net Debt: 543921000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-09-30) — Net Income: 7722000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 7722000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 7722000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 7722000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 7722000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 7722000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-09-30) — Net Interest Income: -6096000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -6096000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-09-30) — Net PPE: 2130792000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 2939728000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 193101000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-09-30) — Non Current Prepaid Assets: 88826000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 45622000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-09-30) — Normalized Income: 7722000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-09-30) — Operating Income: 14129000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-09-30) — Operating Revenue: 1115227000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 13020902.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 77503000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 46345000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 2810226000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 707000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 61719000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 3743000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 131071000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-09-30) — Other Properties: 1993896000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-09-30) — Other Receivables: 107000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 13167000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-09-30) — Payables: 103854000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-09-30) — Pretax Income: 11776000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 888584000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 27750000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 13020902.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 2940435000.00
FAIRCHEMOR.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 2939728000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-09-30) — Tax Provision: 4054000.00
FAIRCHEMOR.NS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.34